Devanshu Singla
Devanshu Singla
The Sensex settled at 81,596.63, up 410.19 points or 0.51 per cent, while the Nifty50 closed at 24,813.45, gaining 129.55 points or 0.52 per cent
Astonea Labs' ₹37.67 crore IPO comprises a fresh issue of 2.79 million equity shares with no offer for sale component
Leela Hotels' owner Schloss Bangalore has set the price band for its IPO in the range of ₹413 to ₹435 per equity share
Nifty Auto emerged as top sectoral laggard, down 2.17 per cent, due to heavyweights like Hero MotoCorp, Bajaj Auto, Maruti Suzuki, TVS Motor, Eicher Motor, and Bharat Forge falling over 2 per cent eac
Blue Water Logistics aims to raise ₹40.50 crore through a fresh issue of 3 million equity shares
Sun Pharma Q4 results date: Sun Pharma is scheduled to announce its fourth quarter results on Thursday, May 22, 2025
The recent moderation in SIP flows is largely a function of short-term sentiment, particularly in response to sharp corrections in small- and mid-cap segments, Rungta said
On the Sectoral front, Nifty IT emerged as top loser down by 1.37 per cent after Moody's downgraded the US government's credit rating on Friday
The Mumbai-based Unified Data Tech Solutions aims to raise ₹144.47 crore through the public issue of 5.29 million equity shares
Indian equity benchmarks settled in red on Friday due to selective profit booking in key sectors such as IT, Metal and Banks
The Kolkata-based company aims to raise ₹25.55 crore through a fresh issue of 4.27 million shares
The rally came after comments from President Trump that India had offered a zero-tariff trade deal to the United States
The better-than-expected retail inflation data and expectations of a good monsoon season ahead have lifted the sentiment around fertiliser stocks
Victory Electric Vehicles IPO: Check price band, lot size, key dates, objective here
Jyothy Labs reported a revenue from operations of ₹667 crore, up merely 1.1 per cent from ₹660 crore in the year-ago period
Navin Fluorine reported a revenue from operations of ₹700.94 crore in Q4 FY25, up 16.44 per cent year-on-year (Y-o-Y) from ₹601.95 crore in the year-ago period
Accretion Pharmaceuticals has set the price band for its IPO in the range of ₹96 to ₹101 apiece
The unlisted shares of Integrity Infrabuild Developers were trading flat at ₹100, the issue price, in the grey market premium
While investors believe in India's long-term growth story and resilience amid global uncertainty, they see near-term risks around the direction of a global trade war, Kapoor said
Dr Reddy's Labs Q4 results 2025 date: Dr Reddy's Laboratories is scheduled to announce its fourth quarter (Q4FY25) results on Friday, May 9, 2025